Andreas Fritsche1,2,3, Andreas Peter1,2,3, Johannes Kufeldt1,2, Marketa Kovarova1,2,3, Michael Adolph4, Harald Staiger2,3,5, Michael Bamberg6, Hans-Ulrich Häring1,2,3. 1. Department of Internal Medicine, Division of Endocrinology, Diabetology, Vascular Medicine, Nephrology, and Clinical Chemistry, University Hospital Tuebingen, Tuebingen Germany. 2. Institute of Diabetes Research and Metabolic Diseases (IDM) of the Helmholtz Center Munich at the University Tuebingen, Tuebingen, Germany. 3. German Center for Diabetes Research (DZD), Munich-Neuherberg, Germany. 4. Department of Anaesthesiology and Intensive Care Medicine, University Hospital Tuebingen, Tuebingen, Germany. 5. Institute of Pharmaceutical Sciences, Department of Pharmacy and Biochemistry, Eberhard Karls University Tuebingen. 6. Managing Medical Director and Chairman of the Board, University Hospital Tuebingen, Tuebingen, Germany.
Authors: Martin Röhling; Marcus Redaélli; Dusan Simic; Kristina Lorrek; Christina Samel; Paul Schneider; Kerstin Kempf; Stephanie Stock; Stephan Martin Journal: Diabetes Metab Syndr Obes Date: 2019-11-29 Impact factor: 3.168
Authors: Marie Auzanneau; Andreas Fritsche; Andrea Icks; Erhard Siegel; Reinhold Kilian; Wolfram Karges; Stefanie Lanzinger; Reinhard W Holl Journal: Dtsch Arztebl Int Date: 2021-06-18 Impact factor: 5.594